Picture a morning, decades from now, somewhere along the Gulf coast. The sun rises over a city that has grown taller and greener at once: glass towers wrapped in vertical gardens, streets humming with quiet electric transit, and clinics woven into ordinary neighborhoods rather than hidden behind hospital walls. Yet the real transformation is almost invisible. Beneath every hospital, every clinic, and every home health pod, a vast web of information moves silently: genomes, vital signs, brain activity, and lifetimes of medical history, all helping doctors understand how to keep people alive longer and better. In Abu Dhabi, a grandmother receives a warning about a heart condition eleven years before it would have become dangerous. Across the emirates, in Al Ain, a teenager recovering from a stroke relearns speech through a neural device that turns intention into words. And in Fujairah, before a newborn has even left the hospital, a rare genetic disorder is identified early enough for treatment to begin before crisis does. None of this feels like science fiction to the people living it. It feels like Tuesday.
This is the future I want to live in: not one where machines have replaced doctors, but one where medicine has finally learned to see the person in front of it, rather than an average built from someone else’s data.
To understand why this vision matters, it helps to look honestly at where we stand today. Artificial intelligence is already reading scans, predicting disease risk, and helping doctors catch cancers earlier than the human eye alone could. Genomic medicine is no longer confined to research laboratories; it is becoming a clinical tool capable of revealing which medications may work for our bodies, which may fail us, and which diseases we might be quietly at risk of long before symptoms appear. Neurotechnology, the field that fascinates me most, is no longer speculative fiction either. It is already helping paralyzed patients move robotic limbs and helping people who have lost the ability to speak find their voices again by reading the brain’s own intentions and translating them into action.
I did not arrive at this subject as an outside observer. One afternoon, after a school discussion on AI in healthcare, a younger student waited until everyone else had left and asked me a question I have not forgotten: if an algorithm can learn from millions of patients, how does it know whether it has learned from someone like me? It was not a technical question, not really. It was a question about trust. As a member of the MBZUAI AI Youth Advisory Board and my school’s STEM and AI Lead Ambassador, I have often found myself in that exact space between excitement and unease, translating the language of models, datasets, and neural interfaces into the language that matters most to ordinary people: Will this understand me? Will it protect me? Was I included when it was made? Those moments have taught me something the headlines rarely mention. The most important question about artificial intelligence and neurotechnology is not only how powerful they will become. It is who is in the room when they are designed, and whose lives were considered before the first line of code was written.
That question becomes urgent once we look closely at how these systems learn. Here is the conflict at the center of this future, the reason this vision cannot be simple celebration: what happens when technology becomes intelligent enough to understand us, but the data it learned from never included people like us?
This is not a hypothetical concern. Medical AI and genomic research are built on enormous datasets, and those datasets are not neutral. They reflect who was studied, who had access to research hospitals, and whose genomes were sequenced first. For decades, that has disproportionately meant populations in North America and Europe, while Arab populations have often remained underrepresented in the genetic research that increasingly underpins modern medicine. A system trained overwhelmingly on one kind of population can, quietly and without malicious intent, become less accurate for everyone else. It will miss what it was never taught to look for. A future built carelessly on top of this problem would not eliminate inequality in healthcare. It would simply make that inequality faster, more confident, and harder to see. This is precisely why the future I imagine cannot simply be about smarter machines. It has to be about whose intelligence they carry forward, and who was given a seat at the table before the decisions were made.
The hopeful part is that this future is not only imaginable; it is already being built, and the United Arab Emirates is one of the places building it. The National Genome Strategy reflects a national commitment to personalized, preventive, and precision medicine, supported by secure genomic infrastructure for research and care. More strikingly, the Emirati Reference Genome Programme exists for exactly the reason this essay describes: to build a genetic reference that represents the diversity of the Emirati population, rather than importing a reference built somewhere else, for someone else. This is what it looks like when a country decides that inclusion in the future of medicine is not a privilege to inherit from elsewhere, but something to build deliberately at home.
Imagine what this looks like when it matures. A doctor in Abu Dhabi does not simply run a symptom through a general algorithm and hope it applies. She consults a system trained in part on genetic and clinical data drawn from the region her patients actually come from, a system that recognizes patterns specific to Gulf populations because it was built, at least in part, to know them. A patient’s genome is not treated as a set of statistics borrowed from another population, but as something the system was designed to interpret accurately from the start. Artificial intelligence does not replace this doctor’s judgment; it sharpens it, surfacing patterns a human eye might miss while leaving the decisions, the empathy, and the relationship where they belong: with a person. Genomic screening catches disease early enough that treatment becomes prevention rather than crisis. Neurotechnology, still the newest and most delicate of these tools, helps restore what illness or injury has taken away: movement, speech, independence, dignity. None of this requires imagining machines more powerful than the ones already being developed. It requires imagining a future where the people building them refuse to let entire populations become an afterthought. That is a future built not only on breakthroughs, but on a more honest definition of intelligence: the recognition that any system, artificial or otherwise, is only as fair as what it was taught to notice.
This is also why I believe my generation cannot afford to be only an audience for this future. We are being handed technologies more powerful than any generation before us has held, and the temptation is to treat them as spectacles, things to marvel at from a distance. But the students I speak to on advisory boards and in classrooms are not going to inherit a finished world. We are going to inherit an unfinished one, still being written, and the decisions about who these systems are built to understand are being made right now, not in some distant future. If there is a responsibility that comes with growing up alongside artificial intelligence and neurotechnology, it is this: not simply to use what is given to us, but to ask, at every step, who was considered, and who was forgotten.
This matters beyond medicine, too, because it says something about what kind of future is actually worth wanting. It would be easy to imagine a future defined only by how advanced our technology becomes: faster processors, sharper algorithms, more precise machines. But a future like that, built without care for who gets included, is not real progress. It is inequality moving faster than before. The future worth building is not the one with the most extraordinary machines. It is the one where those machines make no one feel like an exception, a footnote, or a case the system was never designed to understand.
So when I imagine the future, I do not first imagine a machine. I imagine the quiet second after it works: a doctor pausing before a diagnosis because the data has revealed what a general model would have missed; a patient hearing that their background did not make them invisible; a student, years from now, asking not whether technology is intelligent, but whether it has become wise enough to notice everyone. That is the future I want, and the one I am already trying to help build: a future where medicine does not ask people to fit the system, but builds systems careful enough to meet people as they are.
